Early termination of NCT04617067, a phase II, open label, clinical trial of oral paricalcitol in combination with gemcitabine and NAB-paclitaxel therapy in advanced pancreatic cancer. [PDF]
Easty D +18 more
europepmc +1 more source
Comparison of parathormone lowering effects of paricalcitol and calcitriol in hemodialysis patients. [PDF]
Murt A.
europepmc +1 more source
ROS-responsive graphene-hyaluronic acid nanomedicine for targeted therapy in renal ischemia/reperfusion injury. [PDF]
Lee S +6 more
europepmc +1 more source
Beyond traditional roles: vitamin D and erythropoietin as immune modulators in kidney diseases. [PDF]
Magagnoli L +3 more
europepmc +1 more source
Attenuating amiodarone-induced lung toxicity by the vitamin D receptor activator paricalcitol in rats: targeting TLR4/NF-κB/HIF-1α and TGF-β/Smad signaling pathways. [PDF]
El-Waseif AG +3 more
europepmc +1 more source
In clinical practice, acute coronary syndrome containing acute myocardial infarction (AMI) often leads to systolic dysfunction, cardiac fibrosis and heart failure.
Lai, Chi-Cheng
core
Paricalcitol-mediated vitamin D receptor activation attenuates neuronal ferroptosis via cAMP-PKA-DRP1 signaling pathway after intracerebral hemorrhage. [PDF]
Tian M, Li X, Qi D, Wei P, Jin P.
europepmc +1 more source
Novel Synthesis of Paricalcitol by Chem-biotransformation [PDF]
Yang Wan, Peng Wen, Pan Zhang, Qun Lu
openaire +1 more source
Identification of diagnostic genes and drug prediction of allergic asthma by integrated bioinformatics analysis, machine learning, and molecular docking. [PDF]
Wang H +6 more
europepmc +1 more source
Vitamin D receptor modulates autophagy via miR-20a-5p/ATG16L1 axis to alleviate lipopolysaccharide-induced acute kidney injury. [PDF]
Wei Y +7 more
europepmc +1 more source

